1. Home
  2. PSIX vs NRIX Comparison

PSIX vs NRIX Comparison

Compare PSIX & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PSIX

Power Solutions International Inc.

HOLD

Current Price

$60.01

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$16.35

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSIX
NRIX
Founded
1985
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PSIX
NRIX
Price
$60.01
$16.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
13
Target Price
$98.76
$29.46
AVG Volume (30 Days)
539.0K
702.7K
Earning Date
01-01-0001
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$76,987,000.00
Revenue This Year
$50.35
N/A
Revenue Next Year
$20.10
$26.32
P/E Ratio
$17.20
N/A
Revenue Growth
N/A
99.31
52 Week Low
$18.10
$8.18
52 Week High
$121.47
$22.50

Technical Indicators

Market Signals
Indicator
PSIX
NRIX
Relative Strength Index (RSI) 34.86 49.16
Support Level $49.78 $16.02
Resistance Level $76.03 $16.49
Average True Range (ATR) 7.95 0.78
MACD -3.73 0.11
Stochastic Oscillator 4.07 90.00

Price Performance

Historical Comparison
PSIX
NRIX

About PSIX Power Solutions International Inc.

Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction and irrigation. The company generates majority of its sales from United States.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Share on Social Networks: